The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

SRTX has been attempting to raise fresh financing needed to fund its near-term working capital requirements and stretch its ...

A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a disorder on the radars of several drugmakers.

Under this agreement, SOLVE FSHD will provide strategic funding to support a drug screening initiative led by Transcripta Bio. The project will analyze a broad range of approved and late-stage ...

Investors welcomed reports that the next wave of President Trump's tariffs will be more targeted than threatened.

Investors welcomed reports that the next wave of President Trump's tariffs will be more targeted than threatened.

Intel on Wednesday (Mar 12) named former board member and chip industry veteran Tan Lip-Bu as its CEO and signalled the struggling but storied chipmaker was unlikely to split up its chip-design ...

The company has struggled to compete with rivals like Nvidia, which has seen tremendous success due to its dominance in AI chip production. Before stepping into the CEO role, Tan was a member of ...

Intel, the company powering 70% of the world’s computers, has appointed seasoned executive Lip-Bu Tan as its new CEO. This signals a renewed push to navigate the chipmaker through challenging times.

Shares of Intel Corp. jumped 15% after the company named Lip-Bu Tan as its next chief executive officer, entrusting a former board member and semiconductor veteran with one of the toughest jobs in the ...